Literature DB >> 14996124

Successful treatment of therapy-resistant chronic vegetating pyoderma gangrenosum with infliximab (chimeric antitumour necrosis factor antibody).

L Jenne, B Sauter, P Thumann, M Hertl, G Schuler.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14996124     DOI: 10.1111/j.1365-2133.2003.05760.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  2 in total

1.  [Chronic fistulas with impaired wound healing].

Authors:  A Feser; G Schuler; M Simon; M Lüftl
Journal:  Hautarzt       Date:  2006-09       Impact factor: 0.751

2.  Pyoderma gangrenosum and tumour necrosis factor alpha inhibitors: A semi-systematic review.

Authors:  Hakim Ben Abdallah; Karsten Fogh; Rikke Bech
Journal:  Int Wound J       Date:  2019-01-03       Impact factor: 3.315

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.